FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020.
Mike Blake/File Photo
Under His eye...
Of course they did. THE ONLY ONES GETTING RICHER WHILE THE POOR BECOMES MORE IMPOVERISHED....
That's an interesting news, but it may be too early
Hope combined R&D could expedite coronavirus vaccine.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
2 billion doses of Oxford COVID-19 vaccine planned after Gates funding - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. It is a goodwill initiative, but a mistake. In fact, it may lead to finding vaccine later than expected! How? Well big pharma will push away alternatives that may work but they are not working on. Big money close to power always lead to corruption. I just hope that I am wrong. __MJDr It remains unclear whether the vaccine will work 🤨 So actual cost is $2.50/dose ($750M/300Mdoses). What will be the sale price then?
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »